The Link Between Ulcerative Colitis and Diabetes

The Link Between Ulcerative Colitis and Diabetes

The Link Between Ulcerative Colitis and Diabetes
Ake Ngiamsanguan/iStock; Adobe Stock; iStock

When you have both ulcerative colitis (UC) and diabetes, it’s a balancing act. The two diseases can overlap and interact in frustrating ways, and sometimes treating one condition worsens symptoms of the other.

But there are strategies you can use to manage both diseases and reduce their impact on your daily life.

What Is Diabetic Colitis, and Is It a Real Diagnosis?

Diabetic colitis isn’t an official diagnosis. Diabetes does not cause colitis (inflammation in the colon), says Nicole Jawitz, MD, an assistant professor of medicine at Duke University School of Medicine in Durham, North Carolina, but people with diabetes “can develop colitis-like symptoms, including diarrhea, due to injury to the nerves in the GI tract.”

It’s also possible to have both UC and diabetes at the same time, and the two conditions can interact with each other.

Other causes of colitis-like symptoms in people with diabetes include medication side effects, artificial sweeteners, or other medical diagnoses.

UC is a type of inflammatory bowel disease (IBD) that affects the large intestine and rectum. Treatment involves

medications and in some cases surgery.

Diabetes is a group of metabolic disorders that includes type 1 and type 2 diabetes. With diabetes, the body is unable to produce or use the hormone insulin as it should, which results in high blood glucose levels.

 Although they’re not fundamentally linked, UC and diabetes have similar complications, and each can increase the likelihood of the other.
Chronic intestinal inflammation caused by IBD may increase the risk of type 2 diabetes.

And some UC treatments, like glucocorticoids, can elevate blood glucose levels and contribute to diabetes development and progression.

Type 1 diabetes also has a strong link to UC. Both conditions are autoimmune disorders.

 People with IBD have a higher risk of type 1 diabetes before and after IBD diagnosis than people without IBD. The relationship may be bidirectional, meaning each condition can increase the risk of the other.

5 Complications of Ulcerative Colitis

Ulcerative colitis is an autoimmune disease and a form of IBD. Complications from UC affect more than just the digestive track. Here are some things to watch out for.
5 Complications of Ulcerative Colitis

Shared Complications of Diabetes and UC

Diabetes and UC can cause many similar complications.

  • Problems with the liver and bile ducts: UC inflammation can contribute to primary sclerosing cholangitis, causing liver damage.

     People with type 2 diabetes have a higher risk of bile duct infections and the hard lumps in the gallbladder known as gallstones.

  • Joint and bone problems: People with either condition have a higher risk of osteoporosis and bone fractures.

  • Blood vessel disease: Diabetes can lead to atherosclerosis, a stiffening and narrowing of blood vessels in the heart, brain, kidneys, eyes, and elsewhere.

     UC can also increase a person’s risk of cardiovascular issues due to chronic inflammation and changes to the gut microbes.

  • Complications after surgery: Research suggests that a person with diabetes who undergoes surgery on the colon or rectum has an increased risk of complications, including infection at the surgery site and impaired wound healing.

Medication Challenges

UC is typically treated with anti-inflammatory drugs, but some of these medications make diabetes management more challenging.

Steroids like prednisone, a type of glucocorticoid, are mainstays of UC treatment, but they can raise blood glucose levels.

People with diabetes who are prescribed steroids may need to initiate insulin treatment or increase their insulin dose to reduce blood glucose spikes. This may vary depending on the dose and type of glucocorticoid.

Glucocorticoids also increase insulin resistance, making it harder for the body to use insulin.

As a result, it can become more difficult to keep blood sugar levels in a healthy range, and it may be necessary to intensify your diabetes treatment.

People taking glucocorticoids to manage a UC flare may need to manage their blood glucose levels carefully.

Diabetes Treatment Side Effects

Certain diabetes medications, such as metformin and GLP-1 receptor agonists, may cause gastrointestinal and colitis-like symptoms, including:

  • Diarrhea
  • Nausea
  • Vomiting

People can work with their healthcare provider to manage their treatment side effects and, if experiencing severe symptoms, find alternative treatments or undergo additional testing to rule out other causes.

Treatments for UC and Diabetes

Treatments and lifestyle changes for one condition can affect the other.

Dr. Jawitz advises treating the most active condition first during a flare-up of symptoms. “There may be periods when either a patient's ulcerative colitis or diabetes is more active,” she says. “In these cases, the acute treatment of one condition may be prioritized over the other. Otherwise, ideally both conditions should be routinely monitored and treated at the same time.”

If you’re looking for treatments for diabetes and UC, work with your doctor to find medications that won’t raise your blood sugar levels. Usually, doctors only prescribe glucocorticoids for a short time because of the risk of side effects.

Some UC treatments may even help improve blood sugar management, including:

  • 5-aminosalicylates, like sulfasalazine (Azulfidine), which may lower A1C
  • Biologics, such as infliximab (Remicade), which may reduce insulin resistance

Note that while the research on these medications thus far has been promising, more research is needed to definitely determine their effects on blood sugar levels and diabetes management.

On the other hand, certain drugs or classes of diabetes medications may improve UC treatment by reducing intestinal inflammation.

 These medications include:
  • DPP-4 inhibitors
  • GLP-1 receptor agonists
  • Metformin

Strategies to Manage Ulcerative Colitis and Diabetes

The best course of action is to take prescribed medications and avoid foods that aggravate your ulcerative colitis symptoms. Here are some other ways to manage both diabetes and colitis.

“For patients with both ulcerative colitis and diabetes, a gastroenterology evaluation can be very helpful in discerning the underlying causes of diarrhea and other GI symptoms,” says Jawitz. “An endocrinologist is similarly helpful in managing diabetes, particularly in the context of steroid use in treating ulcerative colitis, as this can result in uncontrolled blood sugar, decreased bone density, and changes in the body's natural neurohormonal signaling.”

Depending on your situation, the endocrinologist or primary care provider may use oral medications, such as metformin, instead of insulin.

The Takeaway

  • People can have both diabetes and ulcerative colitis, and these two diseases interact with each other. UC and diabetes also share complications, like potential liver and gallbladder issues and nerve damage.
  • Steroids taken for UC can raise blood sugar levels, making diabetes management more difficult. People who take these medications may need to use stronger diabetes medications and keep a closer eye on their glucose levels.
  • You may need a team of specialists to help you manage both conditions and find treatments and lifestyle changes that treat each disease without aggravating the other.

Resources We Trust

EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. Ulcerative colitis flare-ups: 5 tips to manage them. Mayo Clinic. July 19, 2023.
  2. Ulcerative Colitis. Cleveland Clinic. November 5, 2023.
  3. What Is Diabetes? National Institute of Diabetes and Digestive and Kidney Disorders. April 2023.
  4. Jess T et al. Inflammatory Bowel Diseases Increase Risk of Type 2 Diabetes in a Nationwide Cohort Study. Clinical Gastroenterology and Hepatology. April 2020.
  5. Cho J et al. Glucocorticoid-Induced Hyperglycemia: A Neglected Problem. Endocrinology and Metabolism. March 27, 2024.
  6. Takahashi K et al. Case Report: Onset of Type 1 Diabetes Mellitus in a Patient With Ulcerative Colitis and Sjogren’s Syndrome Under Euthyroid Hashimoto’s Thyroiditis. Frontiers in Endocrinology. March 17, 2022.
  7. Sun J et al. Bidirectional association between inflammatory bowel disease and type 1 diabetes: a nationwide matched cohort and case-control study. Lancet Regional Health, Europe. November 2024.
  8. Primary sclerosing cholangitis. Mayo Clinic. June 21, 2023.
  9. Cozma M et al. Implications of Type 2 Diabetes Mellitus in Patients with Acute Cholangitis: A Systematic Review of Current Literature. Healthcare. November 2, 2022.
  10. Complications: Ulcerative colitis. National Health Service. November 1, 2022.
  11. Bone and joint issues associated with diabetes. Mayo Clinic. January 19, 2024.
  12. Li Y et al. Diabetic vascular diseases: molecular mechanisms and therapeutic strategies. Signal Transduction and Targeted Therapy. April 10, 2023.
  13. Chen B et al. Inflammatory Bowel Disease and Cardiovascular Diseases. American Journal of Medicine. December 2022.
  14. Tan DJH et al. The influence of diabetes on postoperative complications following colorectal surgery. Techniques in Coloproctology. January 1, 2021.
  15. Malnutrition and IBD. Crohn’s & Colitis Foundation.
  16. Insulin Resistance. Cleveland Clinic. November 21, 2024.
  17. Corcoran C et al. Metformin. StatPearls. August 17, 2023.
  18. GLP-1 Agonists. Cleveland Clinic. July 3, 2023.
  19. Bower JAJ et al. Effect of inflammatory bowel disease treatments on patients with diabetes mellitus. World Journal of Diabetes. August 15, 2021.
  20. Shinzaki S et al. Antidiabetic drugs for IBD: A long but promising road ahead for drug repositioning to target intestinal inflammation. Journal of Gastroenterology. March 24, 2023.

Yuying Luo, MD

Medical Reviewer

Yuying Luo, MD, is an assistant professor of medicine at Mount Sinai West and Morningside in New York City. She aims to deliver evidence-based, patient-centered, and holistic care for her patients.

Her clinical and research focus includes patients with disorders of gut-brain interaction such as irritable bowel syndrome and functional dyspepsia; patients with lower gastrointestinal motility (constipation) disorders and defecatory and anorectal disorders (such as dyssynergic defecation); and women’s gastrointestinal health.

She graduated from Harvard with a bachelor's degree in molecular and cellular biology and received her MD from the NYU Grossman School of Medicine. She completed her residency in internal medicine at the Icahn School of Medicine at Mount Sinai, where she was also chief resident. She completed her gastroenterology fellowship at Mount Sinai Hospital and was also chief fellow.

Adam Felman

Author
Adam is a freelance writer and editor based in Sussex, England. He loves creating content that helps people and animals feel better. His credits include Medical News Today, Greatist, ZOE, MyLifeforce, and Rover, and he also spent a stint as senior updates editor for Screen Rant.

As a hearing aid user and hearing loss advocate, Adam greatly values content that illuminates invisible disabilities. (He's also a music producer and loves the opportunity to explore the junction at which hearing loss and music collide head-on.)

In his spare time, Adam enjoys running along Worthing seafront, hanging out with his rescue dog, Maggie, and performing loop artistry for disgruntled-looking rooms of 10 people or less.